Comparative Pharmacology
Head-to-head clinical analysis: ANSPOR versus BANAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANSPOR versus BANAN.
ANSPOR vs BANAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
BANAN is a potassium-channel opener that hyperpolarizes smooth muscle cells, leading to vasodilation and reduced peripheral vascular resistance.
250-500 mg orally every 6 hours for 10-14 days; maximum 4 g/day.
500 mg orally twice daily for 7-14 days.
None Documented
None Documented
1.5–2 hours in adults with normal renal function; prolonged to 20–30 hours in severe renal impairment (CrCl <10 mL/min)
2.5 hours (normal renal function); prolonged to 6-8 hours in severe renal impairment
Primarily renal (90–95%) as unchanged drug via glomerular filtration and tubular secretion; biliary excretion negligible (<1%)
Renal: 70% unchanged; biliary: 20%; fecal: 10%
Category C
Category C
Cephalosporin Antibiotic
Cephalosporin Antibiotic